Apyx Medical Corporation Reports Preliminary Full Year and Fourth Quarter 2020 Revenue ResultsBusiness Wire • 01/13/21
Apyx Medical Corporation Announces Approval from FDA to Begin Phase II of U.S. IDE StudyBusiness Wire • 11/23/20
Apyx Medical Corporation (APYX) CEO Charlie Goodwin on Q3 2020 Results - Earnings Call TranscriptSeeking Alpha • 11/09/20
Apyx Medical Corporation Announces Two Peer-Reviewed Clinical Publications Evaluating Renuvion's Helium Plasma TechnologyBusiness Wire • 10/20/20
Apyx Medical Corporation to Release Third Quarter of Fiscal Year 2020 Financial Results on November 9, 2020Business Wire • 10/01/20
Apyx Medical Corporation to Participate in Upcoming Investor Conferences in SeptemberBusiness Wire • 08/31/20
Apyx Medical Corporation (APYX) CEO Charlie Goodwin on Q2 2020 Results - Earnings Call TranscriptSeeking Alpha • 08/10/20
Apyx Medical Corporation Announces Regulatory Clearance to Market and Sell its Helium Plasma Technology Products in Five New CountriesBusiness Wire • 06/22/20
Kaskela Law LLC Announces Investigation of Apyx Medical Corp. (APYX) and Encourages Long-Term APYX Stockholders to Contact the FirmPRNewsWire • 06/06/20
ROSEN, NATIONALLY REGARDED INVESTOR COUNSEL, Continues to Investigate Securities Claims Against Apyx Medical Corporation - APYXPRNewsWire • 05/29/20
Apyx Medical Corp (APYX) CEO Charlie Goodwin on Q1 2020 Results - Earnings Call TranscriptSeeking Alpha • 05/13/20
Apyx Medical Corporation (APYX) CEO Charles Goodwin on Q4 2019 Results - Earnings Call TranscriptSeeking Alpha • 03/17/20